“If you’re a company that’s got forty-seven offices worldwide, and all of a sudden your Singapore office is using cognitive enablers, and you’re saying to Congress, ‘I’m moving all my financial operations to Singapore and Taiwan, because it’s legal to use those there,’ you bet that Congress is going to say, ‘Well, O.K.,'” says Zack Lynch of NeuroInsights.

See also: Brain Gain: The underground world of “neuroenhancing” drugs